Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,936 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
Re A, Casari S, Cattaneo C, Facchetti F, Cadeo G, Carosi G, Rossi G. Re A, et al. Among authors: rossi g. Cancer. 2001 Dec 1;92(11):2739-45. doi: 10.1002/1097-0142(20011201)92:11<2739::aid-cncr10121>3.0.co;2-e. Cancer. 2001. PMID: 11753946
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
Re A, Ferrari S, Frata P, Pizzocaro C, Crippa C, Tucci A, Facchetti F, Grazioli L, Magrini SM, Rossi G. Re A, et al. Among authors: rossi g. Ann Oncol. 2008 May;19(5):951-7. doi: 10.1093/annonc/mdm596. Epub 2008 Jan 21. Ann Oncol. 2008. PMID: 18209012 Free article. Clinical Trial.
Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, Tozzi P, Cattaneo C, Casari S, Skert C, Bocci C, Spina M, Allione B, Verga L, Michieli M, Almici C, Leali PF, Tirelli U, Rossi G. Re A, et al. Among authors: rossi g. Bone Marrow Transplant. 2018 Feb;53(2):228-230. doi: 10.1038/bmt.2017.230. Epub 2017 Oct 9. Bone Marrow Transplant. 2018. PMID: 28991244 No abstract available.
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G. Cattaneo C, et al. Among authors: rossi g. J Antimicrob Chemother. 2008 Mar;61(3):721-8. doi: 10.1093/jac/dkm514. Epub 2008 Jan 24. J Antimicrob Chemother. 2008. PMID: 18218645
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
Cattaneo C, Cancelli V, Imberti L, Dobbs K, Sottini A, Pagani C, Belotti A, Re A, Anastasia A, Quaresima V, Tucci A, Chiorini JA, Su HC, Cohen JI, Burbelo PD, Rossi G, Notarangelo LD. Cattaneo C, et al. Among authors: rossi g. Blood Cancer J. 2021 Sep 14;11(9):151. doi: 10.1038/s41408-021-00546-9. Blood Cancer J. 2021. PMID: 34521813 Free PMC article.
5,936 results